HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
批准号:
4693831
负责人:
R SCHNEERSON
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Escherichia coli Haemophilus influenzae Haemophilus influenzae vaccines Streptococcus pneumoniae Streptococcus pneumoniae vaccine antibacterial antibody bacterial antigens bacterial capsules bacterial meningitis bacterial pneumonia bacterial polysaccharides bactericidal immunity child (0-11) enzyme linked immunosorbent assay epiglottis human subject immunization immunoconjugates immunological substance otitis media radioimmunoassay tetanus toxoid
中文摘要
b型流感嗜血杆菌是细菌性脑膜炎的主要病因
英文摘要
Haemophilus influenzae type b is the leading cause of bacterial meningitis
in infants and children and a major cause of septicemia, septic arthritis
pneumonia and epiglottitis. Pneumococcus type 6A is a major cause of
otitis media and the most frequent pneumococcal type causing meningitis and
pneumonia. Anticapsular antibodies are protective; their induction by
purified capsular polysaccharide is hampered by both their poor
immunogenicity in the young age group and lack of anamestic response. In
contrast, conjugates composed of these polysaccharides covalently bound to
tetanus toxoid were immunogenic in laboratory mice and infant rhesus; this
response could be boosted by further injections. Simultaneous injections
of both cojugates with tetanus toxoid or with DTP enhanced the response to
both polysaccharides. Adult volunteers were immunized 2 times at 3 week
intervals with conjugates composed of H. influenzae type b, the closely
related E. coli K100 or Pn6A polysaccharides and tetanus toxoid in the
following schedule: Group 1: Hib-TT, 50 Mug/dose; Group 2: Pn6A TT, 50
Mug/dose; Group 3: Hib-TT, 50 Mug + Pn6A TT, 50 Mug; Group 4: Hib-TT, 50
Mug + K100-TT, 50 Mug; Group 5: Hib-TT, 100 Mug. Local and systemic
reactions were noted in about half of the vaccinees following the first
immunization, especially in the groups that received the 100 Mug dose. No
serious reactions occurred. 50 Mug Hib TT alone was given to grops 3, 4,
and 5 for the 2nd immunization. The antibody responses, assayed by RIA and
ELISA, showed marked increases in antibody levles in greater than 95% of
the volunteers. Hib antibodies increased 180 fold, Pn6A: 7 fold, and TT
10-20 fold. A maximal response occurred in most volunteers after the 1st
injection, with no booster response after the 2nd. No relation was found
between the preimmune levels to the vaccine components or the rate of
antibody rise to the side effects of the vaccines. The isotype and
biological activities of the conjugate-induced Hib antibodies have been
analyzed and compared to those induced by the polysaccharide alone.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BACTERIAL POLYSACCHARIDE CROSS-REACTIVE WITH MENINGOCOCCAL GROUP A POLYSACCHARIDE
-
批准号:3965845
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:3878145
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:3919310
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:3857156
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:3965839
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:3756711
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:3778615
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
BACTERIAL POLYSACCHARIDE CROSS-REACTIVE WITH MENINGOCOCCAL GROUP A POLYSACCHARIDE
-
批准号:4693837
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:5203357
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:2575681
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:6162482
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
ENHANCEMENT OF IMMUNOGENICITY OF CAPSULAR POLYSACCHARIDES PATHOGENIC BACTERIA
-
批准号:4693830
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
HUMAN IMMUNE RESPONSE TO POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
-
批准号:3842359
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R SCHNEERSON
-
依托单位:
海外基金